Bacteria of the genus Brucella infect a range of vertebrates causing a worldwide extended zoonosis. The best-characterized brucellae infect domestic livestock, behaving as stealthy facultative intracellular parasites. This stealthiness depends on envelope molecules with reduced pathogen-associated molecular patterns, as revealed by the low lethality and ability to persist in mice of these bacteria. Infected cells are often engorged with brucellae without signs of distress, suggesting that stealthiness could also reflect an adaptation of the parasite metabolism to use local nutrients without harming the cell. To investigate this, we compared key metabolic abilities of Brucella abortus 2308 Wisconsin (2308W), a cattle biovar 1 virulent strain, and B. suis 513, the reference strain of the ancestral biovar 5 found in wild rodents. B. suis 513 used a larger number of C substrates and showed faster growth rates in vitro, two features similar to those of B. microti, a species phylogenomically close to B. suis biovar 5 that infects voles. However, whereas B. microti shows enhanced lethality and reduced persistence in mice, B. suis 513 was similar to B. abortus 2308W in this regard. Mutant analyses showed that B. suis 513 and B. abortus 2308W were similar in that both depend on phosphoenolpyruvate synthesis for virulence but not on the classical gluconeogenic fructose-1,6-bisphosphatases Fbp-GlpX or on isocitrate lyase (AceA). However, B. suis 513 used pyruvate phosphate dikinase (PpdK) and phosphoenolpyruvate carboxykinase (PckA) for phosphoenolpyruvate synthesis in vitro while B. abortus 2308W used only PpdK. Moreover, whereas PpdK dysfunction causes attenuation of B. abortus 2308W in mice, in B. suis, 513 attenuation occurred only in the Altogether, these results decouple fast growth rates from enhanced mouse lethality in the brucellae and suggest that an Fbp-GlpX-independent gluconeogenic mechanism is ancestral in this group and show differences in central C metabolic steps that may reflect a progressive adaptation to intracellular growth.
Bacteria of the genus Brucella infect a range of vertebrates causing a worldwide extended zoonosis. The best-characterized brucellae infect domestic livestock, behaving as stealthy facultative intracellular parasites. This stealthiness depends on envelope molecules with reduced pathogen-associated molecular patterns, as revealed by the low lethality and ability to persist in mice of these bacteria. Infected cells are often engorged with brucellae without signs of distress, suggesting that stealthiness could also reflect an adaptation of the parasite metabolism to use local nutrients without harming the cell. To investigate this, we compared key metabolic abilities of Brucella abortus 2308 Wisconsin (2308W), a cattle biovar 1 virulent strain, and B. suis 513, the reference strain of the ancestral biovar 5 found in wild rodents. B. suis 513 used a larger number of C substrates and showed faster growth rates in vitro, two features similar to those of B. microti, a species phylogenomically close to B. suis biovar 5 that infects voles. However, whereas B. microti shows enhanced lethality and reduced persistence in mice, B. suis 513 was similar to B. abortus 2308W in this regard. Mutant analyses showed that B. suis 513 and B. abortus 2308W were similar in that both depend on phosphoenolpyruvate synthesis for virulence but not on the classical gluconeogenic fructose-1,6-bisphosphatases Fbp-GlpX or on isocitrate lyase (AceA). However, B. suis 513 used pyruvate phosphate dikinase (PpdK) and phosphoenolpyruvate carboxykinase (PckA) for phosphoenolpyruvate synthesis in vitro while B. abortus 2308W used only PpdK. Moreover, whereas PpdK dysfunction causes attenuation of B. abortus 2308W in mice, in B. suis, 513 attenuation occurred only in the
INTRODUCTION
In order to survive and efficiently replicate, pathogens need to adjust their metabolism to the nutrients available in their hosts. This is the case of the brucellae, a group of Gram-negative bacteria that infect a wide range of vertebrates (Whatmore, 2009; Zheludkov and Tsirelson, 2010; Soler-Lloréns et al., 2016; Al Dahouk et al., 2017) and include facultative intracellular pathogens causing brucellosis, a worldwide distributed zoonosis. Taxonomically, these bacteria are grouped currently in a single genus with up to 12 closely related species 1 , some of which were divided long ago into biovars according to phenotypic criteria (Alton et al., 1988) . Recent studies show that most brucellae form a core group, which includes the "classical" species as well as more recent isolates from a variety of mammals, separated from several early diverging brucellae, which in turn are close to environmental bacteria and opportunistic pathogens of the α-2 Proteobacteria (Soler-Lloréns et al., 2016; Al Dahouk et al., 2017) . Thus far, the core brucellae that infect domestic ruminants (Brucella abortus and B. melitensis) and swine (B. suis biovars 1, 2, and 3) have deserved greater attention undoubtedly because of their early identification and great impact on public health and animal production. Even though these three species are often described as fastidious because of their slow growth and complex requirements for primary isolation (peptone-yeast extract media, often supplemented with serum), under laboratory conditions the strains investigated are auxotrophic for a few vitamins and, but for some strains that seem to require some amino acids (Plommet, 1991 ; see also section "Discussion"), they grow on mineral salts with glutamate-lactate-glycerol or glucose (Gerhardt and Wilson, 1948; Plommet, 1991; Barbier et al., 2018) . However, there is only limited information on the substrates and pathways in their replicative niche, a vacuole connected to ER cisternae and the outer nuclear membrane (Pizarro-Cerdá et al., 1998; Starr et al., 2008; Ronneau et al., 2014; Zúñiga-Ripa et al., 2014; Barbier et al., 2018; Sedzicki et al., 2018) .
The central C metabolism pathways of Brucella have been reviewed recently (Barbier et al., 2018) . Radiorespirometric and biochemical analyses show that B. suis 1330 (reference strain of biovar 1), B. melitensis 16M (reference strain of biovar 1) and B. abortus 2308 [biovar 1, National Animal Disease Laboratory (Ames, IA, United States)] and S19 (attenuated vaccine strain) 1 http://www.bacterio.net/-allnamesac.html can split hexoses into trioses (Robertson and McCullough, 1968) . However, there is no phosphofructokinase (Pfk; Figure 1 ) and glycolysis [i.e., the Embden-Meyerhof-Parnas (EMP)] pathway is thus interrupted. Similarly, although all genes of the EntnerDoudoroff (ED) pathway are present, the dehydratase (Edd) activity could not be detected in the strain tested (S19). Accordingly, the pentose shunt would be the only route that can provide phosphorylated trioses for subsequent oxidation in the tricarboxylic acid (TCA) cycle (Barbier et al., 2018 ; Figure 1) . Surprisingly, a B. abortus 2308 Wisconsin (2308W; see Supplementary Table S1 and Suárez-Esquivel et al., 2016) double fbp and glpX mutant (the canonical gluconeogenic fructose-1,6-bisphosphatase genes; Figure 1 ) grows in gluconeogenic media, albeit at a markedly reduced rate . Moreover, attenuation in BALB/c mice was observed for pyruvate phosphate dikinase (PpdK) and malic enzyme (Mae) mutants but not for mutants in Fbp, GlpX, phosphoenolpyruvate carboxykinase (PckA) or isocitrate lyase (AceA; glyoxylate shunt) (Figure 1 ). These observations suggest that B. abortus 2308W is endowed with unconventional gluconeogenic enzymes and that, during infection, has access to a limited supply of 6 and 5 C substrates that is compensated through anaplerotic routes by TCA intermediates without a critical role of the glyoxylate shunt.
Phylogenomic analyses show that the core brucellae are less uniform than previously assumed on the basis of DNA:DNA hybridization (Verger et al., 1985) . While all B. abortus and B. melitensis biovars group into two clades, the five recognized biovars of B. suis show phylogenomic diversity inconsistent with their grouping into a single species (Moreno et al., 2002; Scholz et al., 2008; Whatmore, 2009; Al Dahouk et al., 2012 ) and a very wide host range. Biovars 1 and 3 of this nominal species infect swine in the countries of America, Asia, and Europe; biovar 2, swine and hares in Europe; biovar 4, Artic and Northern Eurasia reindeers; and biovar 5 were isolated from species of wild rodents in Transcaucasia some 30 years ago (Zheludkov and Tsirelson, 2010) . Since B. suis biovar 5 (reference strain 513) is closer to the ancestral brucellae (Whatmore, 2009; Al Dahouk et al., 2017) , in this work, we examined whether it shares with B. abortus some relevant nutritional characteristics and steps of the central C metabolism, an information that may help to identify pathways that are conserved and may thus be important in the intracellular life of core brucellae. Here, we report similarities and differences and discuss their potential significance in the lifestyle of these bacteria. The differences and similarities between B. suis 513 FIGURE 1 | Central C metabolic network of Brucella (adapted from Zúñiga-Ripa et al., 2014) . The metabolic network includes complete pentoses phosphate, Entner-Doudoroff and gluconeogenesis pathways, as well as a complete tricarboxylic acid cycle including a glyoxylate shunt. The Embden-Meyerohof-Parnas pathway is interrupted due to the lack of phosphofructokinase (Pfk). Black dashed arrows and italics indicate steps for which no putative genes can be identified in Brucella Gray arrows and gray font indicate peripheral pathways. Metabolites: 1,3,bPG, 1,3-bisphosphoglycerate; KDPG, 2-keto-3-deoxy-phosphogluconate; 2PG, 2-phosphoglycerate; 3PG, 3-phosphoglycerate; 6PGL, 6-P-gluconolactone; 6PG, 6-phosphogluconate; AcCoA, acetyl-coenzyme A; AKG, alpha-ketoglutarate; CIT, citrate; ICIT, isocitrate; DHAP, dihydroxyacetone-phosphate; E4P, erythrose-4-phosphate; F1,6bP, fructose-1,6-bisphosphate; F6P, fructose-6-phosphate; FUM, fumarate; G6P, glucose-6-P; GAP, glyceraldehyde-3-phosphate; G3P, glycerol-3-phosphate; GLX, glyoxylate; MAL, malate; OAA, oxaloacetate; PEP, phosphoenolpyruvate; PYR, pyruvate; R5P, ribose-5-P; RIB5P, ribulose-5-P; S7P, sedoheptulose-7-P; SUC, succinate; SucCoA, succinyl-coenzyme A; X5P, xylulose-5-P. Enzymes: Edd, 6-phospho-D-gluconate dehydratase; Gnd, 6-phosphogluconate dehydrogenase; Pgl, 6-phosphogluconolactonase; Acs, acetyl-coenzyme A synthetase; Acn, aconitate hydratase; Akgdh, alpha-ketoglutarate dehydrogenase; GltA, citrate synthase; eno, enolase; Fbp, GlpX, fructose-1,6-bisphosphatase; Fba, fructose bisphosphate aldolase; Fum, fumarase; Zwf, glucose-6-phosphate dehydrogenase; Pgi, glucose-6-phosphate isomerase; Gdh, glutamate dehydrogenase; Gapdh, glyceraldehyde-3-phosphate dehydrogenase; GlpD, glycerol-3-phosphate dehydrogenase; GlpK, glycerol kinase; Idh, isocitrate dehydrogenase; AceA, isocitrate lyase; Eda, 2-dehydro-3-deoxy-phosphogluconate aldolase; Ldh, lactate dehydrogenase; Mdh, malate dehydrogenase; AceB, malate synthase; Mae, malic enzyme; PckA, phosphoenolpyruvate carboxykinase; Ppc, phosphoenolpyruvate carboxylase; Pps, phosphoenolpyruvate synthase; Pfk, phosphofructokinase; Pgk, phosphoglycerate kinase; Gpm, phosphoglycerate mutase; Oad, pyruvate carboxykinase; Pyc, pyruvate carboxylase; Pdh, pyruvate dehydrogenase; Pyk, pyruvate kinase; PpdK, pyruvate phosphate dikinase; Rpi, ribose-5-phosphate isomerase; Rpe, ribulose-5-phosphate-3-epimerase; Sdh, succinate dehydrogenase; Stk, succinyl-coenzyme A synthethase; Tal, transaldolase; Tkt, transketolase; Tpi, triose phosphate isomerase. and B. microti (a species isolated more recently from Microtus arvalis), noticed in the course of this study are also discussed.
MATERIALS AND METHODS

Bacterial Strains and Growth Conditions
The bacterial strains and plasmids used in this study are listed in Supplementary Table S1. All Brucella were handled under BSL-3 containment. The strains resulting from the genetic manipulations described below were characterized according to standard Brucella typing procedures (Alton et al., 1988) : colonial morphology after 3 days of incubation at 37 • C, crystal violet exclusion, urease, acriflavine agglutination, sensitivity to Tb, Wb, Iz, and R/C phages, agglutination with anti-A and anti-M monospecific sera, CO 2 and serum dependence, and susceptibility to thionine blue, fuchsine, and safranin. Bacteria were routinely grown in standard Peptone-Glucose [Biomerieux; bio-Trypcase (17 g/L), bio-Soyase (3 g/L), Glucose (2.5 g/L), NaCl (5 g/L), K 2 HPO 4 (2.5 g/L)] or this media supplemented with agar. The Peptone-Yeast Extract medium used was composed of bacto tryptone (16 g/L), yeast extract (10 g/L), and NaCl (5 g/L) (all from BD Difco). The following antibiotics were used at the indicated concentrations: kanamycin (Km; 50 µg/mL), polymyxin (Pmx; 1.5 µg/mL), and/or chloramphenicol (Cm; 20 µg/mL) (all from Sigma). When needed, media was supplemented with 5% sucrose. All strains were stored in skimmed milk at −80 • C (Scharlau).
To study the phenotype of the metabolic mutants constructed, the defined medium of Gerhardt (glutamate-lactate-glycerol) was used (Gerhardt and Wilson, 1948) . The components for 1 L medium are: glycerol (30 g), lactic acid (5 g), glutamic acid (1.5 g), thiamine (0.2 mg), nicotinic acid (0.2 mg), pantothenic acid (0.04 mg), biotin (0.0001 mg), K 2 HPO 4 (10 g), Na 2 S 2 O 3 ·5H 2 O (0.1 g), MgSO 4 (10 mg), MnSO 4 (0.1 mg), FeSO 4 (0.1 mg), and NaCl (7.5 g). The pH was adjusted to 6.8-7. In addition, a modification of Plommet's medium was also used (Plommet, 1991; Barbier et al., 2014) and 1 L of this medium is composed of thiamine (0.2 g), nicotinic acid (0.2 g), pantothenic acid (0.07 g), biotin (0.1 mg), K 2 HPO 4 (2.3 g), KH 2 PO 4 (3 g), Na 2 S 2 O 3 (0.1 g), MgSO 4 (0.01 g), MnSO 4 (0.1 mg), FeSO 4 (0.1 mg), NaCl (5 g), (NH 4 ) 2 SO 4 (0.5 g), and 1 g/L of substrate. When glutamic acid was used as nitrogen and C source (NH 4 ) 2 SO 4 was not added.
DNA Manipulations
Genomic sequences of the different Brucella species were obtained from the database National Center for Biotechnology Information (NCBI) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Searches for DNA and protein homologies were carried out using NCBI BLAST (Altschul et al., 1990) . Sequence alignments were performed with Clustal Omega (Goujon et al., 2010; Sievers et al., 2011) . Primers were synthesized by Sigma (Haverhill, United Kingdom). DNA sequencing analysis was performed by the Servicio de Secuenciación de CIMA (Centro de Investigación Médica Aplicada, Universidad de Navarra, Pamplona, Spain). Restriction modification enzymes were used under the conditions recommended by the manufacturer. Plasmid and chromosomal DNA were extracted with QIAprep Spin Miniprep (Qiagen) and Ultraclean Microbial DNA Isolation kit (Mo Bio Laboratories), respectively. When needed, DNA was purified from agarose gels using QIAquick Gel Extraction Kit (Qiagen).
Mutagenesis
Construction of the in-frame deletion mutants Bs5 fbp, Bs5 glpX, Bs5 fbp glpX, Bs5 pckA, Bs5 ppdK, Bs5 pckA ppdK, Bs5 mae, Bs5 mae pckA, and Bs5 aceA was done using previously described plasmids and strategy .
Bs5 BMI_I149 (and Bs5 maeBs5 BMI_I149) was obtained using the plasmid pAZI-25 constructed in this work. First, two PCR fragments were generated: oligonucleotides BMI_I149-F1 (5 -GGTTCCGGCTCTTTCTCT TC-3 ) and BMI_I149-R2 (5 -AAAGTCGAGCGCTTCC TTCT-3 ) amplified a 266 bp fragment including codons 1-31 of BMI_I149, as well as 161 bp upstream of the BMI_I149 start codon; oligonucleotides BMI_I149-F3 (5 -AGAAGGAAGCGCTCGACTTTAACCCGAAACTGATGG AACA-3 ) and BMI_I149-R4 (5 -TGGACTTGCGATGACAGA AC-3 ) were used to amplify a 356 bp fragment including the last 240 bp of BMI_I149. A third PCR joined the two fragments together using oligonucleotides BMI_I149-F1 and BMI_I149-R4 for amplification and the complementary regions between BMI_I149-R2 and BMI_I149-F3 for overlapping. The resulting fragment, containing the BMI_I149 deletion allele, was cloned into pCR2.1 (Invitrogen). After sequence verification, the insert was excised as a BamHI-XbaI fragment and cloned in a pJQKm suicide vector (Scupham and Triplett, 1997) . The acquisition of this vector by Brucella after mating with conjugative Escherichia coli S17 λpir was selected by Km and Pmx resistance. The loss of the plasmid concomitant with either a deletion or a return to wild type phenotype was then selected on sucrose. The resulting colonies were screened by PCR with primers BMI_I149-F1 and BMI_I149-R4 which amplified a fragment of 622 bp in the mutant and a fragment of 2599 bp in the revertant strain. To check the mutation, an internal primer (BMI_I149-R5) which hybridized in the non-deleted region was used.
For complementation, the plasmid pAZI-19 previously described (Zúñiga-Ripa et al., 2014) was used.
Growth Curves
Growth curves were obtained using a Bioscreen C (Lab Systems) apparatus. To avoid carry over of media by the inoculum and lengthy lag phases, inocula were obtained from bacteria grown in test media as follows. First, the strains were inoculated into 10 mL of peptone-glucose in a 50 mL flask and incubated at 37 • C with orbital shaking for 18 h. Then, these bacteria were harvested by centrifugation, resuspended in 10 mL of the test medium (peptone-glucose, peptone-yeast extract, glutamatelactate-glycerol, glutamate, or lactate) at an OD 600 nm of 0.1, and incubated at 37 • C with orbital agitation for 18 h. These exponentially growing bacteria were harvested by centrifugation, resuspended at an OD 600 nm of 0.1 in the test medium, dispensed as technical replicates in Bioscreen multiwell plates (200 µL/well; starting OD of 0.05 in the Bioscreen apparatus) and cultivated for 5 days with continuous shaking at 37 • C. Absorbance values at 420-580 nm were automatically recorded at 30-min intervals. All experiments were repeated at least three times. Controls with medium and no bacteria were included in all experiments.
Cell Culture and Infection RAW 264.7 murine macrophages (ATCC TIB-71) were routinely cultured in Dulbecco's Modified Eagle Medium (DMEM; Gibco) with 10% (vol/vol) heat-inactivated fetal bovine serum (Gibco), 1% (vol/vol) L-glutamine (200 nM; Sigma-Aldrich), and 1% (vol/vol) non-essential amino acids (Gibco). Cells were maintained at 37 • C with a 5% CO 2 atmosphere.
Infections were performed as previously described . Briefly, cells were seeded in 24-well plates at an appropriate density (1 × 10 5 cells/well) and infected 24 h later with a multiplicity of infection (MOI) of 50:1. Cells were centrifuged at 400 × g, for 10 min at 4 • C before being incubated for 15 min at 37 • C with 5% CO 2 , washed with fresh medium and incubated for 90 min with medium containing 100 µg/mL of gentamycin. The medium was then replaced by a fresh one containing 25 µg/mL of this antibiotic. At each time point, cells were washed three times with 100 mM PBS (pH 7) before processing, lysed with 0.1% (v/v) Triton X-100 in PBS, and plated on peptone-glucose-agar to determine the number of intracellular bacteria. All experiments were performed in triplicate and results are expressed as means and standard errors (n = 3) of individual log 10 CFU/well. The attenuated B. abortus virB mutant was used as a control (Sieira et al., 2000) .
Virulence Assays in Mice
Seven-week-old female BALB/c mice (Harlan Laboratories, Bicester, United Kingdom) were accommodated in the facilities of Centro de Investigación y Tecnología Agroalimentaria de Aragón (CITA; Registration code ES502970012025) for 2 weeks before and during the experiments, with water and food ad libitum under P3 biosafety containment conditions. The animal handling and other procedures were in accordance with the current European (directive 86/609/EEC) and Spanish (RD 53/2013) legislations, supervised by the Animal Welfare Committee of the CITA .
For each strain, inoculum was prepared from cultures on peptone-glucose-agar at 37 • C. Bacteria were harvested in 10 mM PBS (pH 7), suspended in this diluent to the appropriate concentration and approximately 5 × 10 4 CFU in 0.1 mL administered to each mouse intraperitoneally (exact doses were retrospectively assessed). For each strain, mice (n = 5 per group) were inoculated and the CFU in spleens was determined at different weeks post-inoculation. Mice were anesthetized by intraperitoneal injection and sacrificed by cervical dislocation; spleens were isolated, weighted, homogenized in 9 vol of PBS and CFU counted on peptone-glucose-agar. The identity of the spleen isolates was confirmed by PCR at several points during the infection process. The individual data were normalized by logarithmic transformation, and the mean log 10 CFU/spleen values and the standard deviation (n = 5) were calculated. Statistical significance was evaluated using one-way ANOVA followed by Dunnett's test ( * p < 0.05, * * p < 0.01, * * * p < 0.001, * * * * p < 0.0001).
RESULTS
Brucella suis 513 (Reference Strain of Biovar 5) Uses a Broad Range of Substrates as the Only C Source but It Is Not Prototrophic for Vitamins
Since the growth characteristics and requirements of B. suis 513 are practically unknown, we first examined the ability of this reference strain to grow on common C6, C5, C4, and C3 substrates as the only C source using the vitamins-mineral salts (with ammonium sulfate as N source when necessary) basal medium of Plommet (Plommet, 1991;  5 ) and required at least one additional C source (i.e., glutamate-lactate or glutamate-glycerol; not shown and Zúñiga-Ripa et al., 2014). These differences suggested that B. suis 513 is more prototrophic than B. abortus 2308W (see section "Discussion"), and thus we examined the vitamin requirements of B. suis 513. We found that B. suis 513 required nicotinic acid and thiamine (Supplementary Figure S1) , being in this regard not different from B. abortus, B. melitensis, or the B. suis biovars previously studied, all of which require at least these two vitamins (Koser et al., 1941; Koser and Wright, 1942; McCullough and Dick, 1942a,b; McCullough et al., 1946) .
Brucella suis 513 Shows Faster Growth Rates Than B. abortus 2308W in Gluconeogenic Media That Do Not Depend on Fbp and GlpX
Since the above observations show that we could probe some aspects of the central C pathways of B. suis 513 using simple defined media, we compared first the growth of B. suis 513 with B. abortus 2308W (slow growing) and B. microti CCM4915 (usually described as fast growing) under gluconeogenic conditions (Gerhardt's medium, containing glutamate, lactate, glycerol, mineral salts, and vitamins; henceforth glutamatelactate-glycerol). As can be seen in Figure 2 , the growth curves suggested higher growth rates for B. suis 513 and B. microti CCM4915 depending upon the medium. In peptone-yeast extract, a rich but still gluconeogenic medium where growth factors are abundant, B. suis 513 and B. microti CCM4915 displayed shorter generation times and much higher yields than B. abortus 2308W. These differences almost disappeared when peptone was combined with glucose ( Figure 2) . Taken together, these results suggest that B. suis 513 and B. microti CCM4915, on one hand, and B. abortus 2308W, on the other, differ in gluconeogenic abilities, a hypothesis that was examined in the experiments described below. The brucellae carry homologs of the two canonic fructose-1,6-bisphosphatases (Fbp and GlpX) on which the gluconeogenic pathway depends. Consistent with our previous report , the simultaneous dysfunction of Fbp and GlpX did not affect the growth of B. abortus 2308W in peptone-glucose and impaired but did not abrogate its growth in glutamate-lactate-glycerol (Figure 3) . In contrast, growth of single (Bs5 fbp or Bs5 glpX) or double (Bs5 fbp glpX) bisphosphatase mutants of B. suis 513 was not compromised to any extent in glutamate-lactate-glycerol (Figure 3) . Since B. suis 513 grew on lactate or glutamate as the sole C source, we also tested the mutants on these gluconeogenic substrates. We found that the ability to grow was not affected on lactate, and only slightly for Bs5 fbp and Bs5 fbp glpX but not for Bs5 glpX on glutamate (Figure 3) .
Brucella suis 513 and B. abortus 2308W Differ in Key Steps Connecting Phosphoenolpyruvate and TCA
We then investigated whether growth of B. suis 513 in complex and gluconeogenic media depends on the steps catalyzed by PpdK (phosphoenolpyruvate ↔ pyruvate) and PckA (oxaloacetate → phosphoenolpyruvate) (Figure 1) . As observed for B. abortus 2308W (Figure 4 and Zúñiga-Ripa et al., 2014), deletion of ppdK (Bs5 ppdK) impaired the growth of B. suis 513 on glutamate-lactate-glycerol but not on peptone-glucose (Figure 4) . On the other hand, deletion of pckA had no effect in B. suis 513 (mutant Bs5 pckA; Figure 4 ) or in B. abortus 2308W . Although these observations could be interpreted to mean that, like in B. abortus 2308W (Zúñiga-Ripa et al., 2014), PckA is not functional and gluconeogenesis depends only on PpdK in B. suis 513, we found this hypothesis not to be true because growth on glutamate-lactate-glycerol was abrogated in a double Bs5 pckA ppdK mutant (Figure 4) , indicating that PckA is active in this strain. These results are in keeping with the fact that while B. abortus 2308W pckA carries a frameshift that generates a premature stop codon (TGA) at position 1474-1476, the orthologous codon in B. suis 513 is TGG (tryptophan) (a BLAST search did not reveal any other copy of pckA in the B. abortus 2308W genome).
We further explored the role of PpdK and PckA by growing Bs5 ppdK, Bs5 pckA, and Bs5 pckA ppdK on lactate or glutamate. But for the expected reduction in growth yields, the results obtained in glutamate paralleled those in glutamate-lactate-glycerol (Figure 4) , confirming that the FIGURE 3 | Growth curves in peptone-glucose, glutamate-lactate-glycerol, glutamate, and lactate of B. suis 513 and mutants Bs5 fbp, Bs5 glpX, and Bs5 fbp glpX, and B. abortus 2308W and mutant BAB fbp glpX. Each point represents the mean ± standard error (error bars are within the size of the symbols) of an experiment performed in technical triplicates. The experiment was repeated three times with similar results. steps catalyzed by PckA and PpdK set a clear difference in the metabolism of B. abortus 2308W and B. suis 513 in gluconeogenic substrates. Interestingly, growth of Bs5 ppdK in lactate was unaffected. As the brucellae lack gluconeogenic phosphoenolpyruvate synthase (Pps; Figure 1 ; Barbier et al., 2018) , this result means that TCA cycle intermediates derived from the pyruvate obtained from lactate (Figure 1) can sustain gluconeogenesis. Since this could implicate a malic enzyme (Mae in Figure 1) , we investigated the mae homologs of B. suis 513.
First, we identified a clear homolog of B. abortus 2308W mae in B. suis 513, which is also a homolog of B. microti FIGURE 4 | Growth curves in peptone-glucose, glutamate-lactate-glycerol, glutamate, and lactate of B. suis 513 and mutants Bs5 pckA, Bs5 ppdK, and Bs5 pckA ppdK, and B. abortus 2308W and mutant BAB ppdK. Each point represents the mean ± standard error (error bars are within the size of the symbols) of an experiment performed in technical triplicates. The experiment was repeated three times with similar results.
(strain CCM4915) BMI_I1020. Although in B. microti there is a second ORF annotated as mae (BMI_I149), its B. suis 513 counterpart lacks a thymine at position 1153 that originates a frameshift that could compromise the functionality of the protein. Thus, we started studying the role of the first mae identified. Consistent with the presence of an active enzyme furnishing pyruvate from oxaloacetate (Figure 1) , this Bs5 mae mutant displayed a reduction in growth on glutamate but not on lactate, a phenotype similar to that of its B. abortus 2308W counterpart but for the expected differences in growth rates/yields (Figure 5) . Moreover, growth on glutamate was abrogated in a double Bs5 mae pckA mutant (Figure 5) , the expected result if both Mae and PckA are active and the former acts in tandem with PpdK in gluconeogenesis (Figure 1) . On the other hand, these mutants grew normally on lactate (Figure 5) , as expected if lactate provides pyruvate for both gluconeogenesis and TCA reactions (Figure 1) . Indirectly, the lack of growth of the double mutant on glutamate was coherent with the possibility that the frameshift in the BMI_I149 ortholog results in a nonfunctional protein, and we confirmed this using a double mutant in the B. suis 513 orthologs of BMI_I1020 (mae) and BMI_I149. This double mutant displayed the same growth characteristics as the single Bs5 mae (Supplementary Figure S2) , strongly suggesting that the protein encoded by the BMI_I149 homolog lacks Mae activity in B. suis 513.
The results presented above show that B. suis 513 converts malate to pyruvate via Mae, and oxaloacetate to FIGURE 5 | Growth curves in peptone-glucose, glutamate-lactate-glycerol, glutamate, and lactate of B. suis 513 and mutants Bs5 mae and Bs5 mae pckA, and B. abortus 2308W and mutant BAB mae. Each point represents the mean ± standard error (error bars are within the size of the symbols) of an experiment performed in technical triplicates. The experiment was repeated three times with similar results. phosphoenolpyruvate via PckA. Because these TCA cycle intermediates could be replenished by condensation of acetylCoA with glyoxylate into malate, we constructed an isocitrate lyase (AceA; Figure 1 ) mutant for in vivo studies (see below) on the role of the glyoxylate bypass. As expected, growth of this B. suis 513 mutant was identical to that of the parental strain in peptone-yeast extract, and this mutation had no effect on the growth in glutamate-lactate-glycerol, glutamateglycerol, or lactate-glycerol (results not shown). Similarly, growth was not affected in media containing peptones (not shown), even though acetogenic amino acids (leucine, isoleucine, lysine, phenylalanine, tryptophan, and tyrosine) represent approximately 20% of the peptone amino acid content.
Brucella suis 513 Requires pckA or ppdK but Not mae or aceA for Virulence in Mice
Since analysis of the B. suis 513 mutants in mice requires a definition of the parameters of virulence of the parental strain in this laboratory model and these have not been studied previously, we first inoculated BALB/c mice with 10 4 and 10 5 CFU of B. suis 513. These doses neither caused death nor triggered any signs of septic shock in the next days, a result similar to those that are characteristic of the Brucella species infecting domestic ruminants (Grilló et al., 2012) . Therefore, we inoculated BALB/c mice intraperitoneally with 5 × 10 4 CFU of B. suis 513 or B. abortus 2308W and determined the CFU numbers in spleen in the following weeks (Figure 6A ). At week 2 (acute phase of infection; Grilló et al., 2012) , B. suis 513 reached CFU numbers similar to those obtained with B. abortus. Thereafter, although CFU numbers were approximately 1.5 logs lower than those of B. abortus 2308W, B. suis 513 showed persistence typical of the chronic phase of classical Brucella species (Grilló et al., 2012) . Virulence of B. suis 513 was confirmed in RAW 264.7 macrophages ( Figure 6B) .
Once we knew these characteristics of B. suis 513, we infected BALB/c mice with the above-described B. suis 513 mutants and determined the spleen CFU numbers in the acute and chronic phase of infection (i.e., 2 and 8 weeks after infection, respectively). We found that dysfunction of the genes of the gluconeogenic phosphatases Fbp and GlpX did not result in a decrease in the CFU numbers in the spleen of mice at either infection phase (Figure 7) . Likewise, neither the pckA nor the ppdK mutant displayed CFU numbers different from the wild type control in either infection phase (Figure 7) . On the other hand, the double pckA-ppdK mutant was markedly attenuated in the chronic phase (p ≤ 0.0001) to the extent that we did not detect any bacteria in the spleens of two of the five mice in this group (limit of detection of this method = 3.3 CFU/mL of the homogenized spleen; Grilló et al., 2012) . Altogether, these results strongly suggest that PckA and PpdK are active during the infectious process, either alternatively or simultaneously. In keeping with this interpretation, partial complementation of the double mutant with plasmid pRH001-ppdK (pAZI-19; Supplementary Table S1) restored the ability to persist in the spleens of BALB/c mice (Supplementary Figure S3) . We did not find attenuation for Bs5 mae and Bs5 mae pckA (Figure 7) , which indicates that conversion of malate into pyruvate or oxaloacetate into phosphoenolpyruvate (Figure 1) is not essential for multiplication of B. suis 513 in BALB/c mouse spleen cells. Also, we did not observe attenuation for Bs5 aceA (Figure 7) , meaning that the glyoxylate shunt is not essential either for B. suis 513 multiplication in the spleen of BALB/c mice.
DISCUSSION
Despite repeated isolation from wild rodents in the Caucasus provinces of the former USSR (Meyer, 1976; Vershilova et al., 1983; Corbel, 1984) , there is little accessible information on the in vitro nutritional requirements and virulence of B. suis biovar 5 in standard brucellosis laboratory models. Remarkably, Russian workers described these isolates as displaying "luxurious" growth (Lyamkin et al., 1981) and amino acid oxidative abilities broader than those of B. suis biovar 1 (Lyamkin et al., 1982; Vershilova et al., 1983) , and on these bases they proposed a new "serobiotype" (B. murium; Banai and Corbel, 2010) , which was not accepted later at a time when the taxonomic status of B. suis seemed clear to the Brucella Taxonomy Subcommittee (Meyer, 1976; Vershilova et al., 1983; Corbel, 1984) . Consistent with these reports and the proposal, the reference strain B. suis 513 displayed growth characteristics departing from those of the classical Brucella species, represented in the present work by B. abortus 2308W, and were in this regard more similar to the fast-growing species B. microti. Noteworthy, the natural hosts of B. suis biovar 5 and B. microti are wild rodents, rather than domestic livestock (Vershilova et al., 1983; Corbel, 1984; Scholz et al., 2008) and both are closer to the early diverging brucellae than B. melitensis, B. abortus, or the other B. suis biovars (Whatmore, 2009; Soler-Lloréns et al., 2016; Al Dahouk et al., 2017) . Nevertheless, whereas the B. microti strain investigated so far (CCM 4915) is lethal at doses higher than 10 4 CFU/mouse and is rapidly eliminated from the spleen at non-lethal doses (Jiménez de Bagüés et al., 2010 , 10 5 CFU of B. suis 513 neither caused the death of mice nor triggered any signs of septic shock, and the CFU/spleen profile showed the acute and chronic phases characteristic of B. abortus, B. melitensis, and among B. suis at least that of biovar 1. Although in a different animal model, this observation is in line with those of the Russian workers who found that the B. suis biovar 5 isolates were similar to B. suis biovar 1 in pathogenicity and subsequent pathomorphological changes in guinea pigs . It has been pointed out previously that fast growth and lethality correlate in B. microti CCM 4915 (Jiménez de Bagüés et al., 2010) . It could be that these are two non-causally connected features or that fast growth results in a rapid increase in Brucella pathogenassociated molecular pattern (PAMP)-bearing molecules that could reach lethal levels not attained at the same infectious dose by the slow-growing strains. Although we cannot rule out that the fast growth of B. suis 513 does not contribute to any extent to lower the CFU/spleen counts by bolstering innate immunity recognition, it is clear that, despite its proximity to B. microti in growth rates, host, and phylogenomic position, B. suis 513 ranks with the classical smooth Brucella species in lethality and ability to persist in mice (Jiménez de Bagüés et al., 2011; Grilló et al., 2012) . These observations, which should be confirmed in additional strains, suggest differences in key PAMP-bearing molecules and, coherent with this hypothesis is the lack of reactivity of B. microti LPS in Western blot with monoclonal antibodies recognizing the core-lipid A of B. melitensis, B. abortus, and B. suis biovars 1, 2, and 5 (Zygmunt et al., 2012 ; R. Conde-Álvarez, A. Zúñiga-Ripa, S. Köhler, M. Iriarte, and I. Moriyón, unpublished observations). Indeed, the core-lipid A of the classical species bears the PAMP modifications implicated in reduced innate immunity recognition and lower septic shock lethality (Lapaque et al., 2005) .
Brucella suis 513 being closer to B. abortus 2308W in virulence in mice and macrophages, but more distant in growth rates in gluconeogenic media and in phylogenomic position, these two bacteria represent models suitable for comparing aspects of the central C metabolism of the core brucellae. The inability of B. abortus 2308W to grow on simple substrates as the only C source, most notably glucose, has to be interpreted with care, as this does not necessarily mean differences in central C pathways. The same inability has also been noted for the B. melitensis 16M strain kept in the laboratory of the authors, which requires methionine to grow on glucose and yet is fully virulent (Barbier et al., 2018) . A similar explanation is likely to apply to B. abortus 2308W, as the differences with B. suis 513 in vitro disappear when glucose is combined with peptone (Figure 2) . Indeed, these are aspects not related to the central C pathways in which there could be differences among strains with the same reference number kept in different laboratories, as it is the likely case of B. abortus 2308 variants (Suárez-Esquivel et al., 2016 ; see also below). The main differences and similarities that concern the C pathways specifically investigated here are summarized in Figure 8 , and their potential significance is discussed below.
In vitro, B. suis 513 uses PpdK and PckA for phosphoenolpyruvate synthesis while B. abortus 2308W depends only on PpdK. This is likely to reflect the situation in vivo, because PpdK dysfunction causes attenuation of B. abortus 2308W in mice but not in B. suis 513, in which attenuation occurred only in the double pckA-ppdK mutant. Although these observations strongly suggest that PckA is not essential for multiplication in the host and that, accordingly, it was not positively selected during evolution, we cannot presently extend this hypothesis to all core brucellae. On one hand, the genomes of all B. abortus and B. melitensis sequenced strains show the same pckA frameshift and subsequent stop codon that results in a truncated protein of 491 amino acids, and this is also true of the only B. ovis strain (BOV_2009 strain) sequenced. On the other, the pckA homologs of B. suis biovar 3 (strain 686), 4 (strain 40), or 5 (strain 513), B. neotomae (strain 5K33), B. ceti (strain B1/94), and B. pinnipedialis (strains M292/94/1 and M163/99/10) encode a protein of the same size (536 amino acids) as the Agrobacterium tumefaciens ortholog (for which there is evidence of PckA activity; Liu et al., 2005) , Ochrobactrum anthropi and Mesorhizobium loti. Therefore, whereas the genomic, experimental, and epidemiological data coincide in indicating a role for PpdK but not for PckA in the virulence of B. abortus and B. melitensis in ruminants and accidental hosts like humans and canids, the interpretation of the conservation of pckA in other brucellae would require studies in the corresponding natural hosts.
The reasons for the conservation of PpdK over PckA in B. abortus, B. melitensis, and B. ovis are not obvious. It may be that, as opposed to the exclusively gluconeogenic role of PckA, the bidirectional nature of the PpdK catalyzed pyruvate ↔ phosphoenolpyruvate step makes the latter a more versatile enzyme (Figure 8) . Although the direction of the C flow remains to be determined, it could indeed change during the life cycle of the bacteria depending on the substrates available at different stages, and in such a scenario pckA could become less useful and eventually superfluous. If TCA were the main source of precursors in the animal model, B. suis 513 could obtain phosphoenolpyruvate using Mae and PpdK and/or PckA (a possibility suggested by the in vitro growth with glutamate; Figure 5 ), and loss of PckA in B. abortus would not affect the Mae and PpdK route (able to supply phosphoenolpyruvate; Figure 8 ). This simple picture is in keeping with the attenuation of B. abortus 2308W mae mutants but not with the virulence of the B. suis 513 double mae-pckA mutant (Figure 7 ) and the inability of B. abortus 2308W to grow with glutamate alone in vitro (Table 1 and Figure 3) . A hypothesis that could conciliate all the evidence available is that B. abortus is complementing the use of malate with a non-TCA substrate able to provide phosphoenolpyruvate, and that B. suis 513 uses such a substrate more efficiently, being in this way independent of malate and oxaloacetate. In this regard lactate is an attractive candidate because it can provide pyruvate (and phosphoenolpyruvate using PpdK; Figure 8 ). Moreover, whereas B. abortus 2308W (see below) cannot grow on lactate (Figure 3) and requires glutamate or glycerol as a complement in vitro (Zúñiga-Ripa et al., 2014), B. suis 513 can use lactate as the only source of C (Figure 3) . Recently, on the basis of the availability of glutamate, lactate, and glycerol (and erythritol) in genital tissues, we have speculated that this set of simple C substrates could mimic the nutritional environment in the host (Letesson et al., 2017) . It is thus conceivable that the dependence of B. abortus on at least two C sources and the loss of PckA reflect a progressive adaptation to such a nutritional environment. In this context, the recent work of Czyż et al. (2017) is also relevant, which described that B. abortus 2308 requires lactate dehydrogenase for intracellular survival in THP-1 monocytes. Interestingly, they also found that infected THP-1 monocytes increase glucose consumption and lactate production (a Warburg-like effect). However, the results reported by these authors on the ability of these bacteria to grow on substrates as the only C source do not clearly match those described here. Whereas they reported that a B. abortus 2308 strain was able to metabolize glucose, lactate, glutamate, and erythritol by measuring the reduction of a tetrazolium dye in a basal medium containing micromolar concentrations of arginine, glutamate, cystine, and 0.005% yeast extract, we did not find evidence for B. abortus 2308W use of lactate, glutamate, or glucose by a direct measurement of growth in mineral salts and vitamins. Although the discrepancies are difficult to interpret, and they could be due to the use of different basal media or strains (see above), it is important to note that the different ability of 2308W and the 2308 strain used by Czyż et al. (2017) to use lactate in vitro as the only C source do not contradict the hypothetical importance of lactate in vivo. The L-lactate permease and L-lactate dehydrogenase required for the metabolism of lactate (Barbier et al., 2018 and A. Zúñiga-Ripa, unpublished results) are conserved in all 2308 genomes sequenced and 2308W can use lactate when other substrates are added .
Whereas the experimental and genomic data on the role of PckA and PpdK in the core brucellae agree on the importance of the latter, this is not the case of AceA, the first enzyme of the glyoxylate shunt (Figure 1) . Substrates such as fatty acids, some alcohols and esters, waxes, alkenes, and some methylated compounds enter central C metabolism at the level of acetyl-CoA, and this pathway enables some bacteria to use them as the sole C source (Caspi et al., 2018) . The pathway may be active in some brucellae. Using a reporter system, we described that B. abortus 2308W expresses aceA at the beginning of the exponential phase in peptone-yeast extract-glucose but hardly in glutamate-lactate glycerol and, in a proteomic study in J774 murine macrophages, Al found that aceA is expressed in B. suis 1330 (biovar 1) 48 h after infection. Also, Abdou et al. (2017) reported that a B. suis 1330 (biovar 1) mutant in the regA regulator overexpresses aceA after 3 days in glutamate-lactate-glycerol in an hypoxic persistence model. Using the regA mutant, its complemented strain and an aceA mutant grown in glutamate-lactate-glycerol supplemented with 0.05 mM sodium palmitate and 5 mM ammonium sulfate, these authors found evidence compatible with an active AceA by testing the respective cytosolic fractions with phenylhydrazine in the presence of isocitrate (Abdou et al., 2017) . However, the evidence obtained in the analysis of aceA mutants in virulence models is not uniform. On one hand, infection of BALB/c mice with a B. suis 1330 aceA mutant results in lower CFU/spleen in the first 4 weeks but not at later times with respect to a complemented strain that did not fully restore virulence, and the differences are not reproduced in the liver (Abdou et al., 2017) . On the other, we observed no attenuation for B. suis 513 or, in a previous work , for B. abortus 2308W in the spleens of BALB/c mice in the first 8 weeks. For B. abortus 2308W and B. suis 1330, the discrepancy has been attributed to strain differences (Abdou et al., 2017 ) and the results with B. suis 513 add to the hypothesis of a possible diversity of the brucellae at this level. There are small differences in the amino acid sequence of the respective AceA homologs (Supplementary Figure S4 ) but these are difficult to interpret without testing the activity of the purified proteins. It would be striking that AceA plays a role on virulence in some core brucellae but not in others, and further research is required to clarify these aspects of the central C metabolism of these bacteria. Thus far, the ability of Brucella to grow on fatty acids as the sole C source has not been explored (Gerhardt, 1958) , possibly because of the early demonstration of their toxicity for B. abortus at very low (10-0.1 mg/L) concentrations (Boyd and Casman, 1951) , which could hamper studies in vitro.
Both B. abortus 2308W and B. suis 513 double fbp-glpX mutants were able to grow in gluconeogenic media and, as discussed before , this suggests a hitherto undescribed gluconeogenic pathway (Caspi et al., 2018) possibly implicating a new type of phosphatase. Search for such an enzyme has been elusive (M. C. Durand-Steinhauser, T. Barbier, A. Zúñiga-Ripa, I. Moriyón, and J. J. Letesson, unpublished results) mainly because of the low activity of the hypothetical alternative gluconeogenic pathway in B. abortus, as the poor growth in gluconeogenic media reflects (Figure 3 and Table 1 ). However, the double fbp-glpX mutant of B. suis 513 displays unscathed gluconeogenic ability in very simple media, a phenotype that is facilitating this investigation. Research in progress confirms the hypothesis that a new gluconeogenic enzyme compatible with a new pathway is in fact active in B. suis 513. Also worth commenting upon is the similar phenotype of wild type bacteria of B. suis 513 and B. microti CCM 4915 but not of B. abortus 2308W in gluconeogenic media (Figure 1) . This simple observation suggests that gluconeogenesis is similar in the former two species, that the pathway is ancestral in the core brucellae and that there is a reduction of its efficiency in, at least, B. abortus. Such a reduction would be coherent with a reduced role or even non-essentiality of the pathway in the natural hosts of at least B. abortus, a hypothesis to be tested once the new pathway is fully elucidated.
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